INDIAN BENCHMARKS are likely to open on a flat note as the global cues look mixed with SGX Nifty trading 2 points lower.
Headlines for the day:
- Cipla gets USFDA’s tentative approval for HIV drug Kaletra
- Texmaco Rail & engineering reports spectacular numbers
- Natco Pharma posts healthy operating performance
Trend in FII flows: The FIIs were net buyers of Rs 211.42 Cr in the cash segment on Friday while the DIIs were net buyers of Rs 237.62 Cr, as per the provisional figures released by the NSE.
CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on social network
CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.